News Topic - Merck
Articles 11 - 20 of most recent articles
Merck issues gloomy 2009 guidance
Drug giant Merck, which is building a $750 million manufacturing facility in Durham, said Thursday that 2009 would be worse than Wall Street had expected as the company prepares to deal with a strengthening dollar and a weakening economy. (MRK)
Triangle Business Journal – 20 hours, 55 minutes ago – comment?
found in Local: North Carolina: Raleigh-Durham
Drug giant Merck, which is building a $750 million manufacturing facility in Durham, said Thursday that 2009 would be worse than Wall Street had expected as the company prepares to deal with a strengthening dollar and a weakening economy. (MRK)
Triangle Business Journal – 20 hours, 55 minutes ago – comment?
found in Local: North Carolina: Raleigh-Durham
Merck outlook misses view as dollar strengthens
NEW YORK (Reuters) - Merck & Co forecast 2009 earnings and revenue below Wall Street forecasts on Thursday, citing a harsh impact from the stronger dollar and continuing sluggish sales of several big medicines.
Reuters – 22 hours, 13 minutes ago – comment?
found in Business
NEW YORK (Reuters) - Merck & Co forecast 2009 earnings and revenue below Wall Street forecasts on Thursday, citing a harsh impact from the stronger dollar and continuing sluggish sales of several big medicines.
Reuters – 22 hours, 13 minutes ago – comment?
found in Business
Merck Offers a Cautious Forecast for 2009
The company cited a harsh impact from the stronger dollar and continuing sluggish sales of several big medicines.
New York Times – 22 hours, 14 minutes ago – comment?
found in Business
The company cited a harsh impact from the stronger dollar and continuing sluggish sales of several big medicines.
New York Times – 22 hours, 14 minutes ago – comment?
found in Business
Stocks fall at open on outlooks and sales
NEW YORK (Reuters) - Stocks opened lower on Thursday as disappointing outlooks from blue-chip companies, including drugmaker Merck and chemical maker DuPont , suggested the economic slump is worsening.
Reuters – 23 hours, 50 minutes ago – comment?
found in Business
NEW YORK (Reuters) - Stocks opened lower on Thursday as disappointing outlooks from blue-chip companies, including drugmaker Merck and chemical maker DuPont , suggested the economic slump is worsening.
Reuters – 23 hours, 50 minutes ago – comment?
found in Business
Merck lowers 2009 profit outlook
Read full story for latest details.
CNNMoney.com – Dec 4, 2008 1:43 PM [GMT] – comment?
found in Business: Companies
Read full story for latest details.
CNNMoney.com – Dec 4, 2008 1:43 PM [GMT] – comment?
found in Business: Companies
Movers: DuPont, AT&T, Merck, Nokia, Wal-Mart
Read full story for latest details.
Business Week – Dec 4, 2008 1:28 PM [GMT] – comment?
found in Business: Investing
Read full story for latest details.
Business Week – Dec 4, 2008 1:28 PM [GMT] – comment?
found in Business: Investing
Merck Sees 2009 Earnings Below Estimates
The company said it will maintain its dividend at current levels.
TheStreet.com – Dec 4, 2008 12:59 PM [GMT] – comment?
found in Business: Investing
The company said it will maintain its dividend at current levels.
TheStreet.com – Dec 4, 2008 12:59 PM [GMT] – comment?
found in Business: Investing
Merck projects '09 profit, revenue below forecastsReuters - Merck & Co , which has been hobbled by declining sales of several of its biggest medicines, said on Thursday that it expected 2009 earnings and revenue below Wall Street forecasts.
Yahoo! – Dec 4, 2008 12:28 PM [GMT] – comment?
found in Business
Merck sees 2008 profit at $3.45 to $3.55 a share
NEW YORK (MarketWatch) -- Merck & Co. on Thursday said that for 2008 it sees GAAP earnings per share of $3.45 to $3.55. For 2009, Merck estimates GAAP earnings per share of $3.15 to $3.30, excluding certain items and a 2009 GAAP EPS range of $2.95 to $3.17. Market Pulse Stories are Rapid-fire, ... more »
MarketWatch.com – Dec 4, 2008 12:25 PM [GMT] – comment?
found in Business: Markets
NEW YORK (MarketWatch) -- Merck & Co. on Thursday said that for 2008 it sees GAAP earnings per share of $3.45 to $3.55. For 2009, Merck estimates GAAP earnings per share of $3.15 to $3.30, excluding certain items and a 2009 GAAP EPS range of $2.95 to $3.17. Market Pulse Stories are Rapid-fire, ... more »
MarketWatch.com – Dec 4, 2008 12:25 PM [GMT] – comment?
found in Business: Markets
Allergic reactions to HPV shot are uncommon
A study of Merck & Co Inc's cervical cancer vaccine Gardasil found that allergic reactions were uncommon and most young women can tolerate subsequent doses.
MSNBC.com – Dec 3, 2008 6:30 PM [GMT] – comment?
found in Health
A study of Merck & Co Inc's cervical cancer vaccine Gardasil found that allergic reactions were uncommon and most young women can tolerate subsequent doses.
MSNBC.com – Dec 3, 2008 6:30 PM [GMT] – comment?
found in Health